logo-loader
Moody's Corporation

Big Three ratings agencies could face a new competitor

Much-maligned and even accused of responsibility for the credit crisis of 2007, the credit ratings agencies could soon have a new headache to contend with as US regulators have approved a new service to challenge the Big Three

shutterstock_269244587_57c476f15c3f2.jpg
Measuring up companies faces its own measure up

Much-maligned and even accused of responsibility for the credit crisis of 2007, the top global credit ratings agencies could soon have a new headache to contend with as US regulators have approved a new service to challenge the Big Three.

US securities regulators approved an application from a Morningstar subsidiary to offer credit ratings on companies and financial institutions, an activity that has long been dominated by S&P Global Ratings, Moody’s and Fitch.

Morningstar, which is best known for its one-to-five star ratings on mutual funds, has steadily expanded its credit rating business since the financial crisis, although its principal focus has been on the structured finance universe.

The approval last week from the Securities and Exchange Commission and announced today grants the company the ability to offer credit rating opinions on companies and banks as a nationally recognised statistical rating organisation too.

Japan and China already have their own credit ratings agencies but the latest applicant is the latest from the US or Europe and could pose a larger threat to the established brands.

 

Quick facts: Moody's Corporation

Price: $214.08

Market: NYSE
Market Cap: $40.5 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 22 hours ago

2 min read